Karriere Header Bg
Regask Q1
REGASK-SPONSOREN

7th Annual Life Science Regulatory Intelligence & Strategy Conference

FEBRUARY 26-27, 2025  |  ARLINGTON, VA

Hotel AKA Alexandria, Virginia 22314

Learn more about our session

Lernen Sie unser Team kennen

Verbinden Caroline Schleicher, Founder & CEO, and Kelli Madden, Senior Regulatory Intelligence Manager, as they lead an insightful session on how AI-driven regulatory intelligence is transforming compliance strategies.

Don’t miss Kelli’s deep dive into RegASK’s cutting-edge technology and its real-world impact on streamlining regulatory workflows.

JD Deleon, Business Development Director, will be at the RegASK booth, connecting with professionals across the industry and showcasing how our AI-driven solutions can help organizations navigate global regulatory challenges.

Q1 Conference Attendees

JD Deleon

Direktor für Geschäftsentwicklung

Caroline Schleicher

Founder & CEO

Kelli Madden

Leitender Manager für regulatorische Informationen

RegASK presentations

DAY 1: February 26, 2025 | 9:00 AM – 9:45 AM

Session Title: Autonomous Regulatory Intelligence – The Future of Regulatory Intelligence

Speakers:
Caroline Schleicher, Founder and CEO (RegASK)
Kelli Madden, Senior Regulatory Intelligence Manager (RegASK)

As regulatory landscapes become increasingly complex, staying compliant is more challenging than ever. In this session, Kelli Madden will explore how AI and Machine Learning (ML) can proactively recommend regulatory actions, ensuring compliance while reducing manual effort.

Key Takeaways:
How AI seamlessly integrates into regulatory intelligence
• Real-time monitoring and automation of regulatory updates
• Transforming compliance into a proactive, data-driven process
• Overcoming challenges in AI adoption for regulatory affairs

Join us as we showcase RegASK’s cutting-edge AI-driven regulatory solutions designed to simplify compliance and enhance decision-making.


DAY 2: February 27, 2025 | 1:30 PM – 2:30 PM

Session Title: Solutions for Regulatory Professionals to Ensure Compliance with Global Regulations

Speakers:
Carla Amstein
, Global Head Regulatory Intelligence (Alcon)

Kelli Madden, Senior Regulatory Intelligence Manager (RegASK)

Key Takeaways:
• Methods for seamless compliance management
• Regulatory reporting solutions for data and reports

Your trusted partner in regulatory intelligence

RegASK is proud to sponsor the 7th Annual Life Science Regulatory Intelligence & Strategy Conference, bringing together industry leaders to discuss the future of regulatory intelligence.

As pioneers in AI-driven regulatory solutions, RegASK helps organizations navigate global regulations with speed and accuracy. Our platform provides:

  • Automated regulatory insights tailored to your industry
  • Real-time tracking of regulatory changes and impact analysis
  • A global network of 1,700+ regulatory experts

Join us in shaping the future of regulatory intelligence at this premier event!



Unsere Lösung

RegASK nutzt fortschrittliche KI und maschinelles Lernen, um Unternehmen in stark regulierten Branchen dabei zu unterstützen, ihre Prozesse zur Einhaltung gesetzlicher Vorschriften zu optimieren und stets einen Schritt voraus zu sein. Unsere innovative Lösung automatisiert die regulatorische Forschung, liefert wichtige Erkenntnisse und befähigt Regulatory Affairs-Teams, strategische Partner für das Unternehmenswachstum zu werden.

Ressourcen

Unternehmens-Neuigkeiten

RegASK im Gartner Market Guide für Regulierungen aufgeführt …

Wir freuen uns, mitteilen zu können, dass RegASK in Gartners Market Guide for Regulatory aufgenommen wurde ...

Mehr lesen

Pharma and Biotech Portugal

Portugiesische Industrie lehnt US-Vorschlag für Krebsbekämpfung ab

The United States Health Authority is considering the introduction of mandatory cancer warning labels on...

Mehr lesen

Blogs Reports

Der Bericht zum Stand der Regulierungs- und Compliance-Angelegenheiten im Jahr 2025 …

Is your organization prepared for 2025’s regulatory complexities? The regulatory landscape in 2025 is more...

Mehr lesen

United States Pharma and Biotech

US-amerikanische FDA gibt Leitlinienentwurf zum Einsatz von KI in regulatorischen… bekannt

On January 6, 2025, the U.S. Food and Drug Administration (FDA) announced the release of...

Mehr lesen

United States Pharma and Biotech

US-amerikanische FDA kündigt öffentliche Sitzung zur Gesetzgebung für Kinderarzneimittel an …

The Food and Drug Administration (FDA) has scheduled a public meeting titled “Interested Parties Meeting:...

Mehr lesen

United States Medical Devices

FDA (USA) Issues Final Guidance on Predetermined Change…

On December 4, 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance,...

Mehr lesen

China Medical Devices Pharma and Biotech

China Approves Carbon Ion Therapy, Marking Cancer Treat…

On September 29, 2024, the National Medical Products Administration (NMPA) approved the registration of the...

Mehr lesen